home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9605a.zip
/
M9650126.TXT
< prev
next >
Wrap
Text File
|
1996-03-09
|
2KB
|
39 lines
Document 0126
DOCN M9650126
TI Lamivudine or stavudine in two- and three-drug combinations against
human immunodeficiency virus type 1 replication in vitro.
DT 9605
AU Merrill DP; Moonis M; Chou TC; Hirsch MS; Infectious Disease Unit,
Massachusetts General Hospital, Harvard; Medical School, Boston 02114,
USA.
SO J Infect Dis. 1996 Feb;173(2):355-64. Unique Identifier : AIDSLINE
MED/96162093
AB Two- and three-drug combinations of lamivudine or stavudine with other
antiretroviral drugs were evaluated for activity against human
immunodeficiency virus type 1 (HIV-1) activity in peripheral blood
mononuclear cells. Other agents included zidovudine, didanosine,
nevirapine, and saquinavir. Paired zidovudine-sensitive and -resistant
clinical HIV-1 isolates were used. Additive or synergistic interactions
were observed against the zidovudine-sensitive isolate with the
following combinations: lamivudine-zidovudine, lamivudine-stavudine,
lamivudine-saquinavir, lamivudine-nevirapine, stavudine-zidovudine,
stavudine-didanosine, stavudine-saquinavir, stavudine-nevirapine,
lamivudine-zidovudine-saquinavir, lamivudine-zidovudine-stavudine,
stavudine-zidovudine-nevirapine, lamivudine-zidovudine-nevirapine, and
stavudine-zidovudine-saquinavir. Against the zidovudine-resistant
isolate, additive or synergistic interactions were seen with most two-
and three-drug combinations, but the combination of stavudine-zidovudine
was antagonistic. The clinical implications of these in vitro
observations should be explored.
DE Antiviral Agents/*PHARMACOLOGY Comparative Study Drug Combinations
Drug Synergism Human HIV Seropositivity/VIROLOGY HIV-1/*DRUG
EFFECTS/ISOLATION & PURIF/PHYSIOLOGY Reverse Transcriptase
Inhibitors/*PHARMACOLOGY RNA-Directed DNA Polymerase/DRUG EFFECTS
Stavudine/*PHARMACOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't,
P.H.S. Virus Replication/*DRUG EFFECTS Zalcitabine/*ANALOGS &
DERIVATIVES/PHARMACOLOGY JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).